| A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements RJ Kimmerling, MM Stevens, S Olcum, A Minnah, M Vacha, R LaBella, ... Communications Biology 5 (1), 1295, 2022 | 4 | 2022 |
| Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of Malignancies MM Stevens, RJ Kimmerling, S Olcum, M Vacha, R LaBella, A Minnah, ... JCO Precision Oncology 8, e2300349, 2024 | 2 | 2024 |
| Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements RJ Kimmerling, MM Stevens, S Olcum, A Minnah, M Vacha, R LaBella, ... Communications Biology 6, 2023 | 1 | 2023 |
| Assessing immune system function and status R Kimmerling, S Olcum, M Stevens, A Minnah, M Vacha US Patent App. 17/977,341, 2023 | | 2023 |
| A cell mass-based platform for characterizing immune cell function and response to checkpoint blockade in primary blood and malignant fluid samples R Kimmerling, M Stevens, S Olcum, A Minnah, M Vacha, R LaBella, ... Cancer Research 83 (7_Supplement), 2176-2176, 2023 | | 2023 |
| Calibration of a functional biomarker instrument R Kimmerling, A Minnah, S Olcum, M Stevens, M Vacha US Patent App. 17/732,769, 2022 | | 2022 |
| Calibration of a functional biomarker instrument R Kimmerling, A Minnah, S Olcum, M Stevens, M Vacha US Patent 11,346,755, 2022 | | 2022 |
